The two new terms introduced to America’s ears recently are Right To Try and Compassionate Care. These two measures are being employed in the fight to treat COVID-19, or more commonly know Coronavirus. Right To Try was passed almost 2 years ago by the Trump administration to allow patients, mostly terminal, with the ability to be able to try experimental treatments in hopes it could save their lives.
This controversial measure was passed at the Federal level, although 41 States also have approved this measure. The controversy comes as many have said the FDA was already approving experimental drugs for patient use as they were requested. Either way, Right To Try has come in handy when it comes to Coronavirus treatment as two older drugs for use in the treatment of other diseases could be effective in treating Coronavirus. Could a Malaria drug be what we need in getting ahead of the pandemic curve? We have yet to know, but the fact that Right To Try and Compassionate Care allow doctors to try things to treat the symptoms against all hope is the boost the world needs in seeing a future with Coronavirus under control.
Right To Try And Compassionate Care Requires Data To Be Shared
The head of the FDA pointed out that even though Chloroquine, the Malaria treatment drug, may be effective in treating COVID-19, the dose used to treat Malaria may not do anything for the treatment of Coronavirus. These are the delicate things that must be measured and shared with other members of the medical community as everyone collectively rows this ship ashore for the betterment of all mankind. What an amazing thing to be part of and what a tremendous responsibility in collaborating with some of the greatest minds in infectious disease control!
With the right information shared effectively, we can make great strides in a short timeframe. If we have learned anything from Wuhan, China, withholding information can truly be dangerous for all. Clearly, the best thing we can do is learn how to work together in the medical community. So, where should we all start?
The first step in sharing information in the media community is finding common ground. By that, we mean a complete organization agnostic repository for sharing information. The problem that the medical community has faced is HIPAA compliance. For good reason, organizations have had their own siloed EHR systems to keep patient records and information safe. The problem arises when that information needs to be shared, which has largely been solved by printing information out on paper or compact disc that can be lost or read by unintended eyes. Most Healthcare CIOs break out in hives at the thought of anyone from outside the organizations they are in charge of protecting logging into their systems to make use of the data their systems are storing.
In order for collaboration to happen, a system outside of any one organization has to be the go-to place to work together. If a safe and secure sharing environment were in place and monitored by the FDA and the CDC, how much faster could we work to find treatment?
One System For The Good Of All Is The Key To Cures And Vaccines
Where can the FDA and the CDC get such a healthcare organization agnostic platform to start gathering data for Coronavirus patients? eCare Vault is the first solution of its kind to be poised to do just that. It is a HIPAA compliant, cloud-based platform that works from any computer and handheld device. It’s 24-hour collaboration in the palm of your hand. Healthcare professionals can come around one patient and chart notes, gather information, note progress, communicate with the patient and anyone else who is part of the care team. This solution for patient and clinical trial collaboration couldn’t be a better fit for the uncertain times we face now as we race for an effective treatment. Pandemics require teams solidified toward a goal. eCare Vault is the platform to make it happen. If you’d like to find out more about how eCare Vault could help Right To Try and Compassionate care collaboration possible with today’s COVID-19 pandemic, then contact us today for a free consultation.